FDA WARNING_LETTER - Mylan LLC. - February 24, 2011

FDA WARNING_LETTER for Mylan LLC. on February 24, 2011. Product: Drugs. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Mylan LLC. on February 24, 2011. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

FD&C Act 501(a)(2)(B)

21 CFR 211

21 CFR 211.165(a)

21 CFR 210

21 CFR 211.192

21 U.S.C. 351(a)(2)(B)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Mylan LLC.

Inspection Date

February 24, 2011

Product Type

Drugs

Office

Department of Health and Human Services

People

Maridalia Torres-Irizarry ( District Director )

ID: e30bc1ec-388d-42eb-b068-669c14ffe97b

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox